Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells

Retrovirology

Volumn 6, Issue , 2009, Pages

  Imbeault, Michaël ^a   Ouellet, Michel ^a   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DNA; MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GADD34; UNCLASSIFIED DRUG; INTERFERON;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL POPULATION; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERFERON INDUCTION; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENICITY; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RNA METABOLISM; UPREGULATION; CELL CULTURE; CELL LINE; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE I; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 60749117484     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-5     Document Type: Article

References (67)

1. Gil J BermejoAM Alcami J: HIV and apoptosis: a complex interaction between cell death and virus survival. Prog Mol Subcell Biol 2004, 36:117-149. 15171610
2. Bartz SR Emerman M: Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol 1999, 73(3):1956-1963. 104437 9971775
3. Zauli G Gibellini D Secchiero P Dutartre H Olive D Capitani S Collette Y: Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway. Blood 1999, 93(3):1000-1010. 9920849
4. Muthumani K Choo AY Hwang DS Chattergoon MA Dayes NN Zhang D Lee MD Duvvuri U Weiner DB: Mechanism of HIV-1 viral protein R-induced apoptosis. Biochem Biophys Res Commun 2003, 304(3):583-592. 10.1016/ S0006-291X(03)00631-4 12729593
5. Cottrez F Manca F Dalgleish AG Arenzana-Seisdedos F Capron A Groux H: Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule. J Clin Invest 1997, 99(2):257-266. 507793 9005994 10.1172/ JCI119154
6. de la Fuente C Santiago F Deng L Eadie C Zilberman I Kehn K Maddukuri A Baylor S Wu K Lee CG Pumfery A Kashanchi F: Gene expression profile of HIV-1 Tat expressing cells: A close interplay between proliferative and differentiation signals. BMC Biochem 2002, 3:14. 116586 12069692 10.1186/ 1471-2091-3-14
7. Shaheduzzaman S Krishnan V Petrovic A Bittner M Meltzer P Trent J Venkatesan S Zeichner S: Effects of HIV-1 Nef on cellular gene expression profiles. J Biomed Sci 2002, 9(1):82-96. 10.1007/BF02256581 11810028
8. Galey D Becker K Haughey N Kalehua A Taub D Woodward J Mattson MP Nath A: Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes. J Neurovirol 2003, 9(3):358-371. 10.1080/713831545 12775419
9. Wang Z Trillo-Pazos G Kim SY Canki M Morgello S Sharer LR Gelbard HA Su ZZ Kang DC Brooks AI Fisher PB Volsky DJ: Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol 2004, 10(Suppl 1):25-32. 14982736
10. Kim SY Li J Bentsman G Brooks AI Volsky DJ: Microarray analysis of changes in cellular gene expression induced by productive infection of primary human astrocytes: Implications for HAD. J Neuroimmunol 2004, 157(1-2):17-26. 10.1016/j.jneuroim.2004.08.032 15579276
11. Kramer-Hammerle S Hahn A Brack-Werner R Werner T: Elucidating effects of long-term expression of HIV-1 Nef on astrocytes by microarray, promoter, and literature analyses. Gene 2005, 358:31-38. 10.1016/ j.gene.2005.05.011 15958282
12. Woelk CH Ottones F Plotkin CR Du P Royer CD Rought SE Lozach J Sasik R Kornbluth RS Richman DD Corbeil J: Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res Hum Retroviruses 2004, 20(11):1210-1222. 10.1089/aid.2004.20.1210 15588343
13. Guadalupe M Reay E Sankaran S Prindiville T Flamm J McNeil A Dandekar S: Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003, 77(21):11708-11717. 229357 14557656 10.1128/ JVI.77.21.11708-11717.2003
14. Giri MS Nebozhyn M Showe L Montaner LJ: Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J Leukoc Biol 2006, 80(5):1031-1043. 10.1189/jlb.0306157 16940334
15. Chun TW Justement JS Lempicki RA Yang J Dennis G Jr Hallahan CW Sanford C Pandya P Liu S McLaughlin M Ehler LA Moir S Fauci AS: Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc Natl Acad Sci USA 2003, 100(4):1908-1913. 149932 12552096 10.1073/pnas.0437640100
16. Audige A Urosevic M Schlaepfer E Walker R Powell D Hallenberger S Joller H Simon HU Dummer R Speck RF: Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells. J Immunol 2006, 177(9):6227-6237. 17056552
17. Beausejour Y Tremblay MJ: Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane. J Infect Dis 2004, 190(5):894-902. 10.1086/422698 15295693
18. Tardif MR Tremblay MJ: Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material. J Virol 2003, 77(22):12299-12309. 254246 14581566 10.1128/ JVI.77.22.12299-12309.2003
19. Fortin JF Cantin R Lamontagne G Tremblay M: Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol 1997, 71(5):3588-3596. 191506 9094631
20. Fortin JF Cantin R Tremblay MJ: T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol 1998, 72(3):2105-2112. 109505 9499066
21. Fortin JF Barbeau B Hedman H Lundgren E Tremblay MJ: Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology 1999, 257(1):228-238. 10.1006/viro.1999.9687 10208936
22. Fortin JF Cantin R Bergeron MG Tremblay MJ: Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization. Virology 2000, 268(2):493-503. 10.1006/viro.2000.0190 10704357
23. Bounou S Dumais N Tremblay MJ: Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J Biol Chem 2001, 276(9):6359-6369. 10.1074/jbc.M002198200 11096063
24. Adachi A Gendelman HE Koenig S Folks T Willey R Rabson A Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59(2):284-291. 253077 3016298
25. Paquette JS Fortin JF Blanchard L Tremblay MJ: Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol 1998, 72(11):9329-9336. 110356 9765484
26. Kutsch O Benveniste EN Shaw GM Levy DN: Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol 2002, 76(17):8776-8786. 136999 12163598 10.1128/ JVI.76.17.8776-8786.2002
27. Bounou S Leclerc JE Tremblay MJ: Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J Virol 2002, 76(3):1004-1014. 135853 11773376
28. Perfettini JL Roumier T Castedo M Larochette N Boya P Raynal B Lazar V Ciccosanti F Nardacci R Penninger J Piacentini M Kroemer G: NF-kappaB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope. J Exp Med 2004, 199(5):629-640. 2213296 14993250 10.1084/jem.20031216
29. ACheah PL Looi LM: P53: an overview of over two decades of study. Malays J Pathol 2001, 23(1):9-16. 16329542
30. Mosner J Mummenbrauer T Bauer C Sczakiel G Grosse F Deppert W: Negative feedback regulation of wild-type p53 biosynthesis. Embo J 1995, 14(18):4442-4449. 394536 7556087
31. Haneda M Kojima E Nishikimi A Hasegawa T Nakashima I Isobe K: Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA-damaging stress-induced phospho-serine 15 of p53. FEBS Lett 2004, 567(2-3):171-174. 10.1016/j.febslet.2004.04.066 15178317
32. Yagi A Hasegawa Y Xiao H Haneda M Kojima E Nishikimi A Hasegawa T Shimokata K Isobe K: GADD34 induces p53 phosphorylation and p21/WAF1 transcription. J Cell Biochem 2003, 90(6):1242-1249. 10.1002/jcb.10711 14635196
33. Takaoka A Hayakawa S Yanai H Stoiber D Negishi H Kikuchi H Sasaki S Imai K Shibue T Honda K Taniguchi T: Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003, 424(6948):516-523. 10.1038/nature01850 12872134
34. Pan W Lin J Le CT: How many replicates of arrays are required to detect gene expression changes in microarray experiments? A mixture model approach. Genome Biol 2002, 3(5):rEsearch0022 115224 12049663 10.1186/ gb-2002-3-5-research0022
35. Glass A Henning J Karopka T Scheel T Bansemer S Koczan D Gierl L Rolfs A Gimsa U: Representation of individual gene expression in completely pooled mRNA samples. Biosci Biotechnol Biochem 2005, 69(6):1098-1103. 10.1271/bbb.69.1098 15973040
36. Kendziorski CM Zhang Y Lan H Attie AD: The efficiency of pooling mRNA in microarray experiments. Biostatistics 2003, 4(3):465-477. 10.1093/ biostatistics/4.3.465 12925512
37. Kendziorski C Irizarry RA Chen KS Haag JD Gould MN: On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci USA 2005, 102(12):4252-4257. 552978 15755808 10.1073/pnas.0500607102
38. Peng X Wood CL Blalock EM Chen KC Landfield PW Stromberg AJ: Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 2003, 4:26. 166151 12823867 10.1186/1471-2105-4-26
39. de Ridder D Linden van der CE Schonewille T Dik WA Reinders MJ van Dongen JJ StaaT FJ: Purity for clarity: the need for purification of tumor cells in DNA microarray studies. Leukemia 2005, 19(4):618-627. 15744349
40. Szaniszlo P Wang N Sinha M Reece LM Van Hook JW Luxon BA Leary JF: Getting the right cells to the array: Gene expression microarray analysis of cell mixtures and sorted cells. Cytometry A 2004, 59(2):191-202. 10.1002/cyto.a.20055 15170598
41. Makino M Baba M: A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells. Scand J Immunol 1997, 45(6):618-622. 10.1046/j.1365-3083.1997.d01-441.x 9201301
42. Sonza S Maerz A Deacon N Meanger J Mills J Crowe S: Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 1996, 70(6):3863-3869. 190263 8648722
43. Zhu T Muthui D Holte S Nickle D Feng F Brodie S Hwangbo Y Mullins JI Corey L: Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 2002, 76(2):707-716. 136806 11752161 10.1128/JVI.76.2.707-716.2002
44. Schmidt B Ashlock BM Foster H Fujimura SH Levy JA: HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology 2005, 343(2):256-266. 10.1016/ j.virol.2005.09.059 16278001
45. Fitzgerald-Bocarsly P: Natural interTeron-alpha producing cells: the plasmacytoid dendritic cells. Biotechniques 2002:16-20. 22, 24-19. 12395924
46. Corbeil J Sheeter D Genini D Rought S Leoni L Du P Ferguson M Masys DR Welsh JB Fink JL Sasik R Huang D Drenkow J Richman DD Gingeras T: Temporal gene regulation during HIV-1 infection of human CD4+ T cells. Genome Res 2001, 11(7):1198-1204. 311116 11435401 10.1101/gr.GR-1802R
47. Hupp TR Meek DW Midgley CA Lane DP: Regulation of the specific DNA binding function of p53. Cell 1992, 71(5):875-886. 10.1016/ 0092-8674(92)90562-Q 1423635
48. Perfettini JL Castedo M Roumier T Andreau K Nardacci R Piacentini M Kroemer G: Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ 2005, 12(Suppl 1):916-923. 10.1038/sj.cdd.4401584 15719026
49. Chan EY Qian WJ Diamond DL Liu T Gritsenko MA Monroe ME Camp DG 2nd Smith RD Katze MG: Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: Dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol 2007, 81(14):7571-7583. 1933372 17494070 10.1128/JVI.00288-07
50. Ringrose JH Jeeninga RE Berkhout B Speijer D: Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J Virol 2008, 82(9):4320-4330. 2293043 18287243 10.1128/JVI.01819-07
51. Longo F Marchetti MA Castagnoli L Battaglia PA Gigliani F: A novel approach to protein-protein interaction: Complex formation between the p53 tumor suppressor and the HIV Tat proteins. Biochem Biophys Res Commun 1995, 206(1):326-334. 10.1006/bbrc.1995.1045 7818536
52. Greenway AL McPhee DA Allen K Johnstone R Holloway G Mills J Azad A Sankovich S Lambert P: Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J Virol 2002, 76(6):2692-2702. 135999 11861836 10.1128/ JVI.76.6.2692-2702.2002
53. Sawaya BE Khalili K Mercer WE Denisova L Amini S: Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem 1998, 273(32):20052-20057. 10.1074/jbc.273.32.20052 9685344
54. Ariumi Y Kaida A Hatanaka M Shimotohno K: Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain. Biochem Biophys Res Commun 2001, 287(2):556-561. 10.1006/bbrc.2001.5626 11554765
55. Pauls E Senserrich J Clotet B Este JA: Inhibition of HIV-1 replication by RNA interference of p53 expression. J Leukoc Biol 2006, 80(3):659-667. 10.1189/jlb.0306189 16844765
56. Li CJ Wang C Friedman DJ Pardee AB: Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1995, 92(12):5461-5464. 41714 7777531 10.1073/pnas.92.12.5461
57. Duan L Ozaki I Oakes JW Taylor JP Khalili K Pomerantz RJ: The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J Virol 1994, 68(7):4302-4313. 236353 8207805
58. Takahashi N Kobayashi S Jiang X Kitagori K Imai K Hibi Y Okamoto T: Expression of 53BP2 and ASPP2 proteins from TP53BP2 gene by alternative splicing. Biochem Biophys Res Commun 2004, 315(2):434-438. 10.1016/ j.bbrc.2004.01.079 14766226
59. Iwabuchi K Bartel PL Li B Marraccino R Fields S: Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA 1994, 91(13):6098-6102. 44145 8016121 10.1073/pnas.91.13.6098
60. Naumovski L Cleary ML: The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M. Mol Cell Biol 1996, 16(7):3884-3892. 231385 8668206
61. Yang JP Hori M Takahashi N Kawabe T Kato H Okamoto T: NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene 1999, 18(37):5177-5186. 10.1038/sj.onc.1202904 10498867
62. Helps NR Barker HM Elledge SJ Cohen PT: Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53. FEBS Lett 1995, 377(3):295-300. 10.1016/0014-5793(95)01347-4 8549741
63. Klein C Planker E Diercks T Kessler H Kunkele KP Lang K Hansen S Schwaiger M: NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA. J Biol Chem 2001, 276(52):49020-49027. 10.1074/jbc.M107516200 11606582
64. Kobayashi S Kajino S Takahashi N Kanazawa S Imai K Hibi Y Ohara H Itoh M Okamoto T: 53BP2 induces apoptosis through the mitochondrial death pathway. Genes Cells 2005, 10(3):253-260. 10.1111/ j.1365-2443.2005.00835.x 15743414
65. Munoz-Fontela C Macip S Martinez-Sobrido L Brown L Ashour J Garcia-Sastre A Lee SW Aaronson SA: Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med 2008, 205(8):1929-1938. 10.1084/jem.20080383 18663127
66. Yonezawa A Morita R Takaori-Kondo A Kadowaki N Kitawaki T Hori T Uchiyama T: Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J Virol 2003, 77(6):3777-3784. 149544 12610152 10.1128/JVI.77.6.3777-3784.2003
67. Brenchley JM Price DA Schacker TW Asher TE Silvestri G Rao S Kazzaz Z Bornstein E Lambotte O Altmann D Blazar BR Rodriguez B Teixeira-Johnson L Landay A Martin JN Hecht FM Picker LJ Lederman MM Deeks SG Douek DC: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006. 12(12):1365-1371. 10.1038/nm1511 17115046